Roberto Juan Perez Roman, MD | |
Carretera 129, Km 1.0 Av. San Luis, Arecibo, PR 00613 | |
(787) 650-7272 | |
Not Available |
Full Name | Roberto Juan Perez Roman |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | Carretera 129, Km 1.0 Av. San Luis, Arecibo, Puerto Rico |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265895973 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 22121 (Puerto Rico) | Primary |
Entity Name | Neurospine Pr Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588349153 PECOS PAC ID: 7911366364 Enrollment ID: O20230704000396 |
News Archive
The approach of holidays such as Thanksgiving and Christmas can be anxious times for those suffering from an eating disorder but researchers say they don't have to be difficult.
Genta Incorporated announced that the Company will supply Ganite® (gallium nitrate injection) for a new clinical trial that will be initiated in patients with cystic fibrosis (CF) who may develop serious infections.
Gut hormone-based medications used to treat diabetes, such as GLP-1 receptor agonists, have also been shown to reduce body weight. Researchers have been working to understand how. This study, presented today at the American Diabetes Association's 75th Scientific Sessions, sheds light on how GLP-1 receptor agonists alter the brain's response to food, possibly reducing cravings and increasing satisfaction while eating.
Researchers at The Rockefeller University in New York have conducted a study showing that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – triggers persistent T cell responses that last for at least six months.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Roberto Juan Perez Roman, MD 205-11 Santana, Arecibo, PR 00612-5367 Ph: (787) 650-7272 | Roberto Juan Perez Roman, MD Carretera 129, Km 1.0 Av. San Luis, Arecibo, PR 00613 Ph: (787) 650-7272 |
News Archive
The approach of holidays such as Thanksgiving and Christmas can be anxious times for those suffering from an eating disorder but researchers say they don't have to be difficult.
Genta Incorporated announced that the Company will supply Ganite® (gallium nitrate injection) for a new clinical trial that will be initiated in patients with cystic fibrosis (CF) who may develop serious infections.
Gut hormone-based medications used to treat diabetes, such as GLP-1 receptor agonists, have also been shown to reduce body weight. Researchers have been working to understand how. This study, presented today at the American Diabetes Association's 75th Scientific Sessions, sheds light on how GLP-1 receptor agonists alter the brain's response to food, possibly reducing cravings and increasing satisfaction while eating.
Researchers at The Rockefeller University in New York have conducted a study showing that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – triggers persistent T cell responses that last for at least six months.
› Verified 8 days ago